Skip to content
An Initiative of AVAC
Search

Resource Library

The PrEPWatch Resource Database offers a wide range of material on the status of PrEP as an option for biomedical HIV prevention around the world. Search this database to find step-by-step guidance for rolling out PrEP, summaries of the research to date on safety, efficacy and implementation, tools to assist planning and roll out, country updates on PrEP policy and access, and lessons learned from those efforts.

Filter By
Multiple filters can be used at once

Showing results 21 - 30 of 63

Selected Filters:
11 August 2023

Feasibility of Long Acting Injectable Cabotegravir PrEP Initiation and Administration by Community Health Workers and Early Aspects of the PrEP Injection Care Continuum in a Primary Care Center in Washington, D.C.

This poster presentation, delivered at IAS 2023 by the Whitman-Walker Institute, describes the integration of long acting injectable cabotegravir for PrEP, administered by community health workers, or non medically licensed staff, in a primary health clinic in Washington, D.C., USA.

Research, Service Delivery

Document
14 April 2023

Coordinating Implementation Science for CAB for PrEP: Bridging from the HPTN 083 and 084 Open Label Extensions to Implementation

This document summarises key takeaways from the BioPIC Think Tank on early insights from the HIV Prevention Trials Network (HPTN) 083 and 084 studies’ Open Label Extensions, looking at effectiveness of cabotegravir for PrEP as HIV prevention.

Research

Document
12 April 2023

Important Steps for PrEP Uptake Among Adolescent Men Who Have Sex With Men and Transgender Women in Brazil

This journal article from PLOS ONE analyzed the PrEP uptake process and factors associated with daily oral PrEP initiation among adolescent men who have sex with men and transgender women in Brazil.

Monitoring & Evaluation

External Link
27 February 2023

Acceptability of PrEP among MSM and Transgender Communities: Qualitative findings from two metropolitan cities in India

This article from PLOS One explores the acceptability of PrEP as a HIV prevention tool with gay and bisexual men who have sex with men and trans individuals in Bengaluru and Delhi, India.

Demand Creation/Marketing, Research, Service Delivery

External Link
27 February 2023

Efficacy and Acceptability of ‘Nudges’ Aimed at Promoting Pre-exposure Prophylaxis (PrEP) Use: A survey of overseas born men who have sex with men

This article from Sexual Health discusses the preferences of overseas-born gay and bisexual men who have sex with men in Australia for different behavioural nudges and the effect of nudges on reported likelihood of seeking information about PrEP.

Demand Creation/Marketing, Research, Service Delivery

External Link
20 February 2023

Clinic-Integrated Smartphone App (JomPrEP) to Improve Uptake of HIV Testing and Pre-exposure Prophylaxis Among Men Who Have Sex With Men in Malaysia: Mixed methods evaluation of usability and acceptability

This article from JMIR mHealth and uHealth describes an evaluation of the smartphone app JomPrEP, which provides a virtual platform for Malaysian men who have sex with men to engage in HIV prevention services.

Research, Service Delivery

External Link
6 February 2023

Optimizing Uptake of Long-Acting Injectable Pre-exposure Prophylaxis for HIV Prevention for Men Who Have Sex with Men

This article from AIDS and Behavior describes the results of a discrete choice experiment on preferences for oral or injectable PrEP amongst gay, bisexual, and other men who have sex with men in the USA, including mode of administration, side-effects, monetary cost, and time cost.

Research

External Link
30 January 2023

Same-day Initiation of Oral Pre-exposure Prophylaxis among Gay, Bisexual, and Other Cisgender Men who Have Sex with Men and Transgender Women in Brazil, Mexico, and Peru (ImPrEP): A prospective, single-arm, open-label, multicentre implementation study

This article from The Lancet HIV assesses the feasibility of same-day oral PrEP delivery amongst gay and bisexual men who have sex with men and transgender women in Brazil, Mexico, and Peru.

Service Delivery

External Link
23 January 2023

Cost-effectiveness Analysis of the Daily HIV Pre-exposure Prophylaxis in Men who Have Sex with Men in Barcelona

This article from PLOS One models the cost-effectiveness of daily oral PrEP use amongst gay and bisexual men who have sex with men in Barcelona, Spain.

Financing & Costing, Research

External Link
23 January 2023

Estimating the Impact of HIV PrEP Regimens Containing Long-acting Injectable Cabotegravir or Daily Oral Tenofovir Disoproxil Fumarate/Emtricitabine among Men who Have Sex with Men in the United States: A mathematical modelling study for HPTN 083

This article from The Lancet Regional Health- Americas describes the results of a modelling exercise which compares the potential population-level impact of oral PrEP (TDF/FTC) and Cabotegravir for PrEP among gay and bisexual men who have sex with men in Atlanta, Georgia, USA.

Research

External Link